Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics

Neuropsychiatric Disease and Treatment

Volumn 2, Issue 4, 2006, Pages 583-585

  Nagamine, Takahiko ^a  

^a Seiwakai Kitsunan Hospital   (Japan)

Author keywords

Hypoglycemia; Insulin resistance; Metabolic syndrome; Schizophrenia; Second generation antipsychotics

Indexed keywords

BIPERIDEN; FLUNITRAZEPAM; GLUCOSE; HALOPERIDOL; INSULIN; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; DELUSION; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HALLUCINATION; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; JAPAN; MALE; REMISSION; SCHIZOPHRENIA; THERAPY RESISTANCE; UNCONSCIOUSNESS; VIOLENCE;

EID: 33847337445     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2006.2.4.583     Document Type: Article

References (5)

1. Henderson DC, Cagliero E, Copeland PM, et al. 2005. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents. Arch Gen Psychiatry, 62:19-28.
2. Lieberman JA, Stroup TS, McEvoy JP, et al. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 353:1209-23.
3. Merkersson K. 2004. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro. Eur Neuropsycho-pharmacol, 14:115-9.
4. Newcomer JW, Haupt DW, Fucetola R, et al. 2002. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry, 59:337-45.
5. Osser DN, Najarian DM, Dufresne RL. 1999. Olanzapine increases weight and serum triglyceride levels. J Clin Psychiatry, 60:767-70.